Quick Answer
BIOMARIN PHARMACEUTICAL INC reported Net Income of $348.90 million for fiscal year 2025.
BIOMARIN PHARMACEUTICAL INC Net Income — Annual History
| Fiscal Year | Net Income | YoY Change |
|---|---|---|
| 2025 | $348.90M | -18.3% |
| 2024 | $426.86M | +154.6% |
| 2023 | $167.65M | +18.4% |
| 2022 | $141.56M | +320.9% |
| 2021 | -$64.08M | -107.5% |
| 2020 | $854.03M | +3681.1% |
| 2019 | -$23.85M | +69.1% |
| 2018 | -$77.21M | +34.0% |
| 2017 | -$117.04M | +81.4% |
| 2016 | -$630.21M | -266.8% |
| 2015 | -$171.80M | -28.2% |
| 2014 | -$133.97M | +24.0% |
| 2013 | -$176.35M | -54.2% |
| 2012 | -$114.35M | -112.4% |
| 2011 | -$53.84M | -126.2% |
| 2010 | $205.82M | +42276.0% |
| 2009 | -$488.0K | -101.6% |
| 2008 | $30.83M | — |
Quarterly Net Income
| Quarter Ending | Net Income | YoY | QoQ |
|---|---|---|---|
| September 30, 2025 | -$30.74M | -129.0% | -112.8% |
| June 30, 2025 | $240.53M | +124.4% | +29.5% |
| March 31, 2025 | $185.69M | +109.4% | +75.0% |
| September 30, 2024 | $106.08M | +162.7% | -1.0% |
| June 30, 2024 | $107.17M | +91.2% | +20.9% |
| March 31, 2024 | $88.66M | +74.4% | +119.6% |
| September 30, 2023 | $40.38M | +707.0% | -27.9% |
| June 30, 2023 | $56.04M | +102.6% | +10.2% |
- BIOMARIN PHARMACEUTICAL INC showed a decrease of -18.3% in Net Income compared to the prior fiscal year.
- Over the 2008–2025 period, BIOMARIN PHARMACEUTICAL INC’s net income has grown by 1031.7% (from $30.83 million to $348.90 million).
- The most recent figure is from BIOMARIN PHARMACEUTICAL INC’s fiscal year 2025 report (Form 10-K), filed with the SEC on February 26, 2026.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: